Myasthenia gravis
We correct the autoimmune response in myasthenia, restoring neuromuscular transmission without suppressing general immunity.
About the disease
Myasthenia gravis is an autoimmune disease in which antibodies block the signal passing from nerve to muscle. This causes muscle weakness and rapid fatigue that worsen toward evening and after exertion. The goal of treatment is to restore neuromuscular transmission and bring back strength.
We use T-cell autoimmunotherapy. It acts selectively on the immune cells that trigger the production of pathogenic antibodies and does not suppress overall immunity.
This is a fundamental difference from the usual regimen. Standard treatment often relies on steroids and drugs that suppress immunity entirely, with all their side effects during long-term use. Immunotherapy works precisely.
The method is used to control the autoimmune response and support muscle strength. It is built into the overall plan alongside disease-modifying therapy under a neurologist's supervision.
The physician selects the regimen after assessing the form of myasthenia, severity, prior treatment, and records. The program is built individually.
Restoring muscle strength
The method helps return neuromuscular transmission.
Without general immunosuppression
The effect is selective; overall immunity is not suppressed.
Precise action
Works on the cells that trigger antibody production.
Fewer side effects
An alternative to long-term steroid use.
Under a neurologist's supervision
Built into the overall plan alongside disease-modifying therapy.
T-cell vaccination
The method aims to stimulate immune reactions selectively directed at inactivating pathogenic autoimmune T-lymphocytes.
Collection and isolation
Autoaggressive T-lymphocytes — cells attacking the body's own tissues — are isolated from your blood.
Vaccine preparation
The isolated cells are processed and used to create a personalized T-cell vaccine.
Vaccination
Administering the vaccine triggers a regulatory immune response that selectively suppresses only the pathogenic cell clones.
Monitoring and support
Inflammatory activity decreases without suppressing general immunity; the course is adjusted based on dynamics.
Frequently asked questions
How does immunotherapy help in myasthenia gravis?
The method acts on the immune cells that trigger the production of antibodies which block the nerve-to-muscle signal. This helps restore muscle strength and reduce fatigue.
Is overall immunity suppressed?
No. T-cell autoimmunotherapy acts selectively and does not suppress the body's whole defense, unlike steroids and general immunosuppressants.
How does the method differ from steroid treatment?
Steroids and general immunosuppressants suppress immunity entirely and cause side effects during long-term use. Immunotherapy works precisely on the cells that sustain the disease.
Can the method be combined with neurologist care?
Yes. Immunotherapy is built into the overall plan together with disease-modifying therapy and neurologist supervision; it complements them.
How does the treatment go?
After a consultation and assessment of the form and severity of myasthenia, the physician builds an individual program. The method is gently tolerated and does not require constant immune suppression.
Can I come for treatment from another region?
Yes. The clinic is near Moscow (Khimki, Skhodnya) and accepts patients from other regions. The first consultation can be held remotely.
Other directions
Multiple sclerosis
Selective inactivation of aggressive lymphocytes to protect the myelin sheath of nerve fibers.
Rheumatoid arthritis
Relief of joint inflammation and restoration of mobility without suppressing general immunity.
Scleroderma
Correction of the immune response to stop excessive collagen production and protect internal organs.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.